Anti–PD-1 Immunotherapy in Microsatellite-Stable Tumors With 10 or More Mutations per Megabase
Interview with Luc GT Morris, MD MSc, author of Response Rates to Anti–PD-1 Immunotherapy in Microsatellite-Stable Solid Tumors With 10 or More Mutations per Megabase
don't worry if you don't have an account with us, we'll create one
[{"meta":{"author":"JAMA Oncology Author Interviews","authorlink":""},"src":"http:\/\/traffic.libsyn.com\/jamaoncologyauthorinterviews\/AntiPD-1_Immunotherapy_in_Microsatellite-Stable_Tumors_With_10_or_More_Mutations_per_Megabase.mp3?dest-id=422099","thumb":{"src":"https:\/\/images.lystnfm.com\/tr:n-app_thumbnail_medium\/podcastsnw-202106\/66dbed-5d40-b7a4-b70a28_800.jpg"},"title":"Anti\u2013PD-1 Immunotherapy in Microsatellite-Stable Tumors With 10 or More Mutations per Megabase","link":"javascript:;","id":"item-437961"}]